Alexion Pharma Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Accounting, Tax Preparation, Bookkeeping, and Payroll Services | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Advertising, Public Relations, and Related Services | Advertising Agencies | Convention and Trade Show Organizers | All Other Support Services

Full name: Alexion Pharma Poland Sp. z o.o.

Profile Updated: April 26, 2025

Alexion Pharma Poland Sp. z o.o. is a company in Poland, with a head office in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. Alexion Pharma Poland Sp. z o.o. was incorporated on March 17, 2022. The company’s latest financial report indicates a net sales revenue increase of 1165.73% in 2025. Its total assets grew by 691.1% over the same period. Alexion Pharma Poland Sp. z o.o.’s net profit margin decreased by 2.99% in 2025.

Headquarters
Ul. Postepu 14
Warsaw; Mazowieckie; Postal Code: 02-676

Contact Details: Purchase the Alexion Pharma Poland Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Alexion Pharma Poland Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Alexion Pharma Poland Sp. z o.o. report to view the information.

Incorporation Date:

March 17, 2022

Key Executives

Purchase this report to view the information.

Management Board Member

Purchase this report to view the information.

Management Board Member

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Alexion Pharma Poland Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

1165.73%▲

Total Operating Revenue

1165.73%▲

Operating Profit

1193.32%▲

Net Profit/Loss for the Period

523.57%▲

Total Assets

691.1%▲

Total Equity

735.96%▲

Operating Profit Margin

0.17%▲

Net Profit Margin

-2.99%▼

Return on Equity (ROE)

-29.98%▼

Similar companies